These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 12950120)
1. Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD. Lee KB; Kim UK Yonsei Med J; 2003 Aug; 44(4):641-7. PubMed ID: 12950120 [TBL] [Abstract][Full Text] [Related]
2. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease. Ramanathan G; Elumalai R; Periyasamy S; Lakkakula B Iran J Kidney Dis; 2014 Jul; 8(4):265-77. PubMed ID: 25001132 [TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824 [TBL] [Abstract][Full Text] [Related]
4. Association between the A1166C polymorphism of the angiotensin II receptor type 1 and progression of chronic renal insufficiency. Coll E; Campos B; González-Núñez D; Botey A; Poch E J Nephrol; 2003; 16(3):357-64. PubMed ID: 12832734 [TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Lovati E; Richard A; Frey BM; Frey FJ; Ferrari P Kidney Int; 2001 Jul; 60(1):46-54. PubMed ID: 11422735 [TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients. Akman B; Tarhan C; Arat Z; Sezer S; Ozdemir FN Ren Fail; 2009; 31(3):196-200. PubMed ID: 19288324 [TBL] [Abstract][Full Text] [Related]
9. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease. Lee KB; Kim UK; Lee CC J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692 [TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Buraczyńska M; Pijanowski Z; Spasiewicz D; Nowicka T; Sodolski T; Widomska - Czekajska T; Ksiazek A Kardiol Pol; 2003 Jan; 58(1):1-9. PubMed ID: 14502296 [TBL] [Abstract][Full Text] [Related]
11. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease. Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482 [TBL] [Abstract][Full Text] [Related]
12. [Progression of autosomic dominant polycystic kidney disease. Influence of endothelial NO synthase (ecNOS) and renin angiotensin system gene polymorphisms]. Azurmendi P; Fraga A; Muchnik C; Dos Ramos Farias M; Galan F; Guerra D; O'Flaherty M; Arrizurieta E; Martin R Medicina (B Aires); 2004; 64(2):139-42. PubMed ID: 15628301 [TBL] [Abstract][Full Text] [Related]
13. Study of the polymorphism of angiotensinogen, anigiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan. Chang HR; Cheng CH; Shu KH; Chen CH; Lian JD; Wu MY J Chin Med Assoc; 2003 Jan; 66(1):51-6. PubMed ID: 12728975 [TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of renin-angiotensin system and progression of interstitial nephritis. Buraczyńska M; Grzebalska A; Spasiewicz D; Orłowska G; Ksiazek A Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):330-6. PubMed ID: 12898858 [TBL] [Abstract][Full Text] [Related]
15. Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease. Reiterová J; Merta M; Stekrová J; Cabartová Z; Cibulka R; Maixnerová D; Rysavá R; Ríhová Z; Tesar V; Motán J Kidney Blood Press Res; 2006; 29(3):182-8. PubMed ID: 16943682 [TBL] [Abstract][Full Text] [Related]
16. The influence of the endothelin-converting enzyme-1 gene polymorphism on the progression of autosomal dominant polycystic kidney disease. Reiterová J; Merta M; Stekrová J; Tesar V; Kmentová D; Ríhová Z; Rysavá R; Viklický O Ren Fail; 2006; 28(1):21-4. PubMed ID: 16526315 [TBL] [Abstract][Full Text] [Related]
17. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Baboolal K; Ravine D; Daniels J; Williams N; Holmans P; Coles GA; Williams JD Kidney Int; 1997 Sep; 52(3):607-13. PubMed ID: 9291178 [TBL] [Abstract][Full Text] [Related]
18. [Renin-angiotensin system genes in chronic glomerulonephritis]. Buraczyńska M; Jóźwiak L; Spasiewicz D; Nowicka T; Ksiazek A Pol Arch Med Wewn; 2001 Jun; 105(6):455-60. PubMed ID: 11865575 [TBL] [Abstract][Full Text] [Related]
19. Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy: IGARAS--a study of 274 Men. Frimat L; Philippe C; Maghakian MN; Jonveaux P; DE Ligny BH; Guillemin F; Kessler M J Am Soc Nephrol; 2000 Nov; 11(11):2062-2067. PubMed ID: 11053482 [TBL] [Abstract][Full Text] [Related]
20. Association between gene polymorphisms of the components of the renin-angiotensin-aldosteron system, graft function, and the prevalence of hypertension, anemia, and erythrocytosis after kidney transplantation. Kujawa-Szewieczek A; Kolonko A; Kocierz M; Szotowska M; Trusolt W; Karkoszka H; Gumprecht J; Chudek J; Więcek A Transplant Proc; 2011 Oct; 43(8):2957-63. PubMed ID: 21996200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]